Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper, Katelyn A Pastick, Nicole Engen, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 8, pp. 623-631
Open Access | Times Cited: 533

Showing 1-25 of 533 citing articles:

Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
Mild or Moderate Covid-19
Rajesh T. Gandhi, John B. Lynch, Carlos del Rı́o
New England Journal of Medicine (2020) Vol. 383, Iss. 18, pp. 1757-1766
Closed Access | Times Cited: 1274
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 423
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
COVID-19 and Solid Organ Transplantation: A Review Article
Yorg Azzi, Rachel Bartash, Joseph R. Scalea, et al.
Transplantation (2020) Vol. 105, Iss. 1, pp. 37-55
Open Access | Times Cited: 286
COVID-19: A review of therapeutic strategies and vaccine candidates
Vladislav Izda, Matlock A. Jeffries, Amr H. Sawalha
Clinical Immunology (2020) Vol. 222, pp. 108634-108634
Open Access | Times Cited: 272
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher Butler, Jienchi Dorward, Ly‐Mee Yu, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1063-1074
Open Access | Times Cited: 272
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 272
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward, et al.
The Lancet (2021) Vol. 398, Iss. 10303, pp. 843-855
Open Access | Times Cited: 263
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 7, pp. 599-610
Open Access | Times Cited: 203
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
COVID-19 in transplant recipients: The Spanish experience
Elisabeth Coll, Mario Fernández‐Ruiz, J. Emilio Sánchez-Álvarez, et al.
American Journal of Transplantation (2020) Vol. 21, Iss. 5, pp. 1825-1837
Open Access | Times Cited: 189
Bots and Misinformation Spread on Social Media: Implications for COVID-19
McKenzie Himelein-Wachowiak, Salvatore Giorgi, Amanda Devoto, et al.
Journal of Medical Internet Research (2021) Vol. 23, Iss. 5, pp. e26933-e26933
Open Access | Times Cited: 150
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1059-1103
Open Access | Times Cited: 147
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 222-238
Open Access | Times Cited: 139
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
Philip James, Zakari Ali, Andrew E. Armitage, et al.
Journal of Nutrition (2021) Vol. 151, Iss. 7, pp. 1854-1878
Open Access | Times Cited: 128
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e216468-e216468
Open Access | Times Cited: 127
Neutralizing Antibody Therapeutics for COVID-19
Aeron C. Hurt, Adam K. Wheatley
Viruses (2021) Vol. 13, Iss. 4, pp. 628-628
Open Access | Times Cited: 118
COVID-19: Pulmonary and Extra Pulmonary Manifestations
Islam Elrobaa, Karl J. New
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 116
Page 1 - Next Page

Scroll to top